The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
Váldodahkki: | Jackson, M |
---|---|
Eará dahkkit: | Vallis, K |
Materiálatiipa: | Oahppočájánas |
Giella: | English |
Almmustuhtton: |
2013
|
Fáttát: |
Geahča maid
-
Selective targeting of homologous recombination deficiency
Dahkki: Zimmer, J
Almmustuhtton: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
Dahkki: Albukhari, A
Almmustuhtton: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
Dahkki: Albukhari, A
Almmustuhtton: (2014) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
Dahkki: Potter, M
Almmustuhtton: (2014) -
Radiopharmaceutical Validation for Clinical Use
Dahkki: Charles A. Kunos, et al.
Almmustuhtton: (2021-03-01)